Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

TTK Healthcare

Sector: Healthcare | Industry: Drugs & Pharma
R 482.65 -4.35  | -0.89% -39.02% 39.62 683.70
NSE Price: Nov 19, 15:57 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 19, 15:57 482.65 -4.35 -0.89% 482.40 487.00 2,310 475.00 - 487.00
BSE Nov 19, 2019 483.85 -5.45 -1.11% 491.70 489.30 28 480.00 - 491.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 2,456 P/B: 2.80 NSE Code: TTKHLTCARE
52-Week Range: R 420.00 - 919.90 Dividend Yield: 1.03% BSE Code: 507747
TTM EPS: R 12.21 Book Value: R 172.60 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Astrazeneca Pharma India (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 37 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
TTK Healthcare -38.88 7.91 2.94 -38.76 -19.24 -9.57 8.43
S&P BSE Small Cap* -9.14 1.80 6.18 -7.71 4.03 3.15 5.84
S&P BSE Healthcare* -5.48 4.16 5.48 -8.24 -4.70 -2.30 10.88
Company's return has been calculated on basis of BSE's price.
As on Nov 19, 2019
*As on Nov 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.72 6.56 8.57
Net Profit 34.18 2.45 14.49
EPS 34.18 -16.08 1.58
Book Value 8.07 0.99 5.80
Average
Operating Margin 9.13 8.73 8.51
Net Margin 3.83 3.48 3.61
Return on Networth 10.25 10.98 13.27
Return on Investment 15.46 16.50 18.81
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -7.69 -0.75 18.08
Operating Profit 0.56 -32.61 -14.24
Net Profit 3.90 -43.22 -23.69
EPS 3.90 -43.22 -23.69
TTM
Revenue -0.20 0.28 0.67
Operating Profit -10.04 -37.70 -21.55
Net Profit -14.29 -50.38 -29.20
EPS -14.29 -61.49 -29.20
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
TTK Healthcare 683.70 632.10 17.26 2.70 10.25 2.80 39.62
Astrazeneca Pharma India 6,498.50 818.54 74.85 8.97 20.03 19.72 86.82
Eris Lifesciences 5,801.27 1,026.31 310.85 29.43 28.96 4.38 18.65
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Nov 30, 2018 Sanjeev Rawat  Sell Market 800 745.85 5.97
Nov 28, 2018 Sanjeev Rawat  Sell Market 700 751.25 5.26
Nov 27, 2018 Sanjeev Rawat  Sell Market 300 755.95 2.27
Jul 20, 2018 VIDHIT TULSHAN  Buy Gift 10,000 754.70 75.47
May 21, 2018 s Sarala Tulshan  Sell Gift 20,192 930.40 187.87
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Axis Mutual Fund 2.299 2.299 2.299 2.299 2.299
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: TTK Healthcare Ltd.

Address: No 6 , Cathedral Road, Chennai, Tamil Nadu - 600086 | Phone: 044-28116106/28116107/28116108/28116109/10 | Fax: 044-28116387

Email: [email protected]

Website: www.ttkhealthcare.com

Registrar & Transfer Agent: Data Software Research Co Pvt Ltd

Address: 9 Pycroft Garden Road, Off Haddows Road, Nungambakkam, Chennai-600006, 9 Pycroft Garden Road, Off Haddows Road, Nungambakkam | Phone: 91-044-28212154/2207 | Fax: 91-044-28212133

Email: [email protected]

Essential checks
Altman Z-Score
5.39
Piotroski F-Score
7
Modified C-Score
4
5-Years Price to Earnings
39.62
5-Years Price to Book
2.80
Earnings Yield
EBIT / Enterprise value
5.16%
PEG
Price / Earnings to growth ratio
9.75
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,600.65 -1.24%
Caplin Point Laboratories R346.85 -2.12%
Eris Lifesciences R422.55 +2.44%
FDC R198.50 +2.37%
Granules India R128.55 +0.23%
Laurus Labs R341.20 +1.11%
Strides Pharma Science R381.05 +0.29%
Sun Pharma Adv. Research R153.50 -0.81%
Suven Life Sciences R302.95 +0.41%
Wockhardt R288.70 -2.68%
As on Nov 19, 15:59